Skip to content
2000
Volume 22, Issue 2
  • ISSN: 1871-5257
  • E-ISSN: 1875-6182

Abstract

Background

Nattokinase (NK) is a naturally occurring fibrinolytic protease enzyme obtained from the traditional Japanese food called Natto and has several uses in the pharmaceutical and medical industries. Nowadays, the most often used thrombolytic agent in the clinical field is NK, in part because it is less expensive than other thrombolytic medicines.

Objectives

The objective of this study is to investigate the screening, isolation and characterization of the NK enzyme-producing strain from fermented Soya beans.

Methods

The sample of fermented soya beans were tested for the presence of fibrinolytic protease-producing bacteria, followed by the screening, extraction, characterization and clot lysis assays.

Results

A total of three isolates were screened for caseinolytic activities by casein hydrolysis assay. Out of those isolates, MRS18 was found to be potent in producing the enzyme proteinase. To determine the taxonomy and phylogeny of these isolates, biochemical and molecular characterization has been carried out. has been found with the highest caseinolytic activity. The clot lysing ability of the potent strain was found to be 61.7% after 120 min, and on further purification, by ammonium sulphate precipitation method, the lysis percentage was found to be 656% after 120 min.

Conclusion

From the results of the present study, we concluded that isolated from the fermented soya beans produced an NK enzyme that exhibits immense potential to lyse blood clots.

Loading

Article metrics loading...

/content/journals/chamc/10.2174/0118715257275639231219054353
2024-06-01
2024-11-29
Loading full text...

Full text loading...

References

  1. MendisS. Global atlas on cardiovascular disease prevention and control.World Health Organization2011
    [Google Scholar]
  2. SeattleW. GBD compare data visualization.2017Available from: https://www.healthdata.org/data-tools-practices/interactive-visuals/gbd-compare
  3. JamaliN. Nattokinase: Structure, applications and sources.Biocatal. Agric. Biotechnol.202247102564
    [Google Scholar]
  4. KunduJ. KunduS. Cardiovascular disease (CVD) and its associated risk factors among older adults in India: Evidence from LASI Wave 1.Clin. Epidemiol. Glob. Health20221310093710.1016/j.cegh.2021.100937
    [Google Scholar]
  5. RengaswamyD. Abdul RahimP. Fibrinolytic enzyme-an overview.Curr. Pharm. Biotechnol.202223111336134510.2174/138920102366622010414311334983344
    [Google Scholar]
  6. SelvarajanE. BhatnagarN. Nattokinase: An updated critical review on challenges and perspectives.Cardiovasc. Hematol. Agents Med. Chem.2017
    [Google Scholar]
  7. KotbE. The biotechnological potential of fibrinolytic enzymes in the dissolution of endogenous blood thrombi.Biotechnol. Prog.201430365667210.1002/btpr.191824799449
    [Google Scholar]
  8. JeongY.K. ParkJ.U. BaekH. ParkS.H. KongI.S. KimD.W. JooW.H. Purification and biochemical characterization of a fibrinolytic enzyme from Bacillus subtilis BK-17.World J. Microbiol. Biotechnol.2001171899210.1023/A:1016685411809
    [Google Scholar]
  9. WengY. YaoJ. SparksS. WangK. Nattokinase: An oral antithrombotic agent for the prevention of cardiovascular disease.Int. J. Mol. Sci.201718352310.3390/ijms1803052328264497
    [Google Scholar]
  10. CollenD. LijnenH. Basic and clinical aspects of fibrinolysis and thrombolysis.Blood19911781231143124
    [Google Scholar]
  11. KumarS.S. SabuA. Fibrinolytic enzymes for thrombolytic therapy.Adv. Exp. Med. Biol.2019114834538110.1007/978‑981‑13‑7709‑9_15
    [Google Scholar]
  12. KotbE. Microbial fibrinolytic enzyme production and applications.Microbial Functional Foods and Nutraceuticals.John Wiley & Sons Ltd.2017175213
    [Google Scholar]
  13. Merlyn KeziahS. Subathra DeviC. Molecular identification of autochthonous bacterial fibrinolytic protein producers from fermentative food preparations.Indian J. Biotechnol.202120154162
    [Google Scholar]
  14. DubeyR. Isolation, production, purification, assay and characterization of fibrinolytic enzymes (Nattokinase, Streptokinase and Urokinase) from bacterial sources.Afr. J. Biotechnol.201110814081420
    [Google Scholar]
  15. BrownJ.H. Bergey’s manual of determinative bacteriology.American Public Health Association1939
    [Google Scholar]
  16. AdhoniS.A. ShivasharanaC. KaliwalB. Identification and characterisation of chlorella vulgaris for biodiesel production.Int. J. Scient. Res. Eng. Stud201631
    [Google Scholar]
  17. HolmströmB. SeppäläP. VilhunenR. EnariT-M. Streptokinase assay on large agar diffusion plates.Acta Chem. Scand.19651971549155410.3891/acta.chem.scand.19‑15494955306
    [Google Scholar]
  18. JoH.D. LeeH.A. JeongS.J. KimJ.H. Purification and characterization of a major fibrinolytic enzyme from Bacillus amyloliquefaciens MJ5-41 isolated from Meju.J. Microbiol. Biotechnol.201121111166117310.4014/jmb.1106.0600822127128
    [Google Scholar]
  19. NwaguT.N. UgwuodoC.J. OnwosiC.O. InyimaO. UchenduO.C. AkpuruC. Evaluation of the probiotic attributes of Bacillus strains isolated from traditional fermented African locust bean seeds (Parkia biglobosa), “daddawa.Ann. Microbiol.20207012010.1186/s13213‑020‑01564‑x
    [Google Scholar]
  20. OuobaL.I.I. ThorsenL. VarnamA.H. Enterotoxins and emetic toxins production by Bacillus cereus and other species of Bacillus isolated from Soumbala and Bikalga, African alkaline fermented food condiments.Int. J. Food Microbiol.2008124322423010.1016/j.ijfoodmicro.2008.03.02618474404
    [Google Scholar]
  21. OdunfaS.A. AdeyeleS. Microbiological changes during the traditional production of ogi-baba, a West African fermented sorghum gruel.J. Cereal Sci.19853217318010.1016/S0733‑5210(85)80027‑8
    [Google Scholar]
  22. SrinivasanV.M. Screening for staphylokinase producing Staphylococcus spp. from bovine milk sample.Int. J. Pharm. Pharm. Sci.201352601
    [Google Scholar]
  23. DeviC.S. MohanasrinivasanV. SharmaP. DasD. VaishnaviB. NaineS.J. Production, purification and stability studies on nattokinase: A therapeutic protein extracted from mutant Pseudomonas aeruginosa CMSS isolated from bovine milk.Int. J. Pept. Res. Ther.201622226326910.1007/s10989‑015‑9505‑5
    [Google Scholar]
  24. SumiH. HamadaH. NakanishiK. HirataniH. Enhancement of the fibrinolytic activity in plasma by oral administration of nattokinase.Acta Haematol.199084313914310.1159/0002050512123064
    [Google Scholar]
  25. HsiaC.H. ShenM.C. LinJ.S. WenY.K. HwangK.L. ChamT.M. YangN.C. Nattokinase decreases plasma levels of fibrinogen, factor VII, and factor VIII in human subjects.Nutr. Res.200929319019610.1016/j.nutres.2009.01.00919358933
    [Google Scholar]
  26. ObeidA. AlawadA.M. IbrahimH.M. Isolation and characterization of bacillus subtillus with potential production of nattokinase.Int. J. Adv. Res.20153394101
    [Google Scholar]
  27. PengY. YangX. ZhangY. Microbial fibrinolytic enzymes: An overview of source, production, properties, and thrombolytic activity in vivo.Appl. Microbiol. Biotechnol.200569212613210.1007/s00253‑005‑0159‑716211381
    [Google Scholar]
/content/journals/chamc/10.2174/0118715257275639231219054353
Loading
/content/journals/chamc/10.2174/0118715257275639231219054353
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test